Dr. Peetra Magnusson research’s focused on immunothrombosis and vascular protection, performing pre-clinical analysis and pharmaceutical targets. She produces patient-derived iPSCs and vascularized organoids and as partners in the SSF Center CNSx3 brain, organoids in microfluidics, patient biobanks, and computational methods will be utilised aiming for novel therapies against brain disease. She collaborates with clinicians in Uppsala, Helsinki, Berlin, and Milan.
Peetra Magnusson
Uppsala University
Key Publications
BMI1 Inhibition Improves Lesion Burden in Cerebral Cavernous Malformations
Circulation, 2024
SproutAngio: an open-source bioimage informatics tool for quantitative analysis of sprouting angiogenesis and lumen space
Scientific Reports, 2023
Stromal transdifferentiation drives lipomatosis and induces extensive vascular remodeling in the aging human lymph node
The Journal of Pathology, 2023
Slow-Closing Clip for the Treatment of Nonsaccular Vertebrobasilar Aneurysms: A Retrospective Case Series
World Neurosurgery, 2022
Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations
International Journal of Molecular Sciences, 2022